List of Tables
Table 1. Global Therapeutic Monoclonal Antibodies Drug Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Therapeutic Monoclonal Antibodies Drug Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Therapeutic Monoclonal Antibodies Drug Production Capacity (Tons) by Manufacturers in 2024
Table 4. Global Therapeutic Monoclonal Antibodies Drug Production by Manufacturers (2020-2025) & (Tons)
Table 5. Global Therapeutic Monoclonal Antibodies Drug Production Market Share by Manufacturers (2020-2025)
Table 6. Global Therapeutic Monoclonal Antibodies Drug Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Therapeutic Monoclonal Antibodies Drug Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Therapeutic Monoclonal Antibodies Drug, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Therapeutic Monoclonal Antibodies Drug as of 2024)
Table 10. Global Market Therapeutic Monoclonal Antibodies Drug Average Price by Manufacturers (US$/Ton) & (2020-2025)
Table 11. Global Key Manufacturers of Therapeutic Monoclonal Antibodies Drug, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Therapeutic Monoclonal Antibodies Drug, Product Offered and Application
Table 13. Global Key Manufacturers of Therapeutic Monoclonal Antibodies Drug, Date of Enter into This Industry
Table 14. Global Therapeutic Monoclonal Antibodies Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Therapeutic Monoclonal Antibodies Drug Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Therapeutic Monoclonal Antibodies Drug Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Region (2020-2025)
Table 19. Global Therapeutic Monoclonal Antibodies Drug Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Therapeutic Monoclonal Antibodies Drug Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Therapeutic Monoclonal Antibodies Drug Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Therapeutic Monoclonal Antibodies Drug Production (Tons) by Region (2020-2025)
Table 23. Global Therapeutic Monoclonal Antibodies Drug Production Market Share by Region (2020-2025)
Table 24. Global Therapeutic Monoclonal Antibodies Drug Production (Tons) Forecast by Region (2026-2031)
Table 25. Global Therapeutic Monoclonal Antibodies Drug Production Market Share Forecast by Region (2026-2031)
Table 26. Global Therapeutic Monoclonal Antibodies Drug Market Average Price (US$/Ton) by Region (2020-2025)
Table 27. Global Therapeutic Monoclonal Antibodies Drug Market Average Price (US$/Ton) by Region (2026-2031)
Table 28. Global Therapeutic Monoclonal Antibodies Drug Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 29. Global Therapeutic Monoclonal Antibodies Drug Consumption by Region (2020-2025) & (Tons)
Table 30. Global Therapeutic Monoclonal Antibodies Drug Consumption Market Share by Region (2020-2025)
Table 31. Global Therapeutic Monoclonal Antibodies Drug Forecasted Consumption by Region (2026-2031) & (Tons)
Table 32. Global Therapeutic Monoclonal Antibodies Drug Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Therapeutic Monoclonal Antibodies Drug Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 34. North America Therapeutic Monoclonal Antibodies Drug Consumption by Country (2020-2025) & (Tons)
Table 35. North America Therapeutic Monoclonal Antibodies Drug Consumption by Country (2026-2031) & (Tons)
Table 36. Europe Therapeutic Monoclonal Antibodies Drug Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 37. Europe Therapeutic Monoclonal Antibodies Drug Consumption by Country (2020-2025) & (Tons)
Table 38. Europe Therapeutic Monoclonal Antibodies Drug Consumption by Country (2026-2031) & (Tons)
Table 39. Asia Pacific Therapeutic Monoclonal Antibodies Drug Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 40. Asia Pacific Therapeutic Monoclonal Antibodies Drug Consumption by Region (2020-2025) & (Tons)
Table 41. Asia Pacific Therapeutic Monoclonal Antibodies Drug Consumption by Region (2026-2031) & (Tons)
Table 42. Latin America, Middle East & Africa Therapeutic Monoclonal Antibodies Drug Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 43. Latin America, Middle East & Africa Therapeutic Monoclonal Antibodies Drug Consumption by Country (2020-2025) & (Tons)
Table 44. Latin America, Middle East & Africa Therapeutic Monoclonal Antibodies Drug Consumption by Country (2026-2031) & (Tons)
Table 45. Global Therapeutic Monoclonal Antibodies Drug Production (Tons) by Type (2020-2025)
Table 46. Global Therapeutic Monoclonal Antibodies Drug Production (Tons) by Type (2026-2031)
Table 47. Global Therapeutic Monoclonal Antibodies Drug Production Market Share by Type (2020-2025)
Table 48. Global Therapeutic Monoclonal Antibodies Drug Production Market Share by Type (2026-2031)
Table 49. Global Therapeutic Monoclonal Antibodies Drug Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Therapeutic Monoclonal Antibodies Drug Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Type (2020-2025)
Table 52. Global Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Type (2026-2031)
Table 53. Global Therapeutic Monoclonal Antibodies Drug Price (US$/Ton) by Type (2020-2025)
Table 54. Global Therapeutic Monoclonal Antibodies Drug Price (US$/Ton) by Type (2026-2031)
Table 55. Global Therapeutic Monoclonal Antibodies Drug Production (Tons) by Application (2020-2025)
Table 56. Global Therapeutic Monoclonal Antibodies Drug Production (Tons) by Application (2026-2031)
Table 57. Global Therapeutic Monoclonal Antibodies Drug Production Market Share by Application (2020-2025)
Table 58. Global Therapeutic Monoclonal Antibodies Drug Production Market Share by Application (2026-2031)
Table 59. Global Therapeutic Monoclonal Antibodies Drug Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Therapeutic Monoclonal Antibodies Drug Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Application (2020-2025)
Table 62. Global Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Application (2026-2031)
Table 63. Global Therapeutic Monoclonal Antibodies Drug Price (US$/Ton) by Application (2020-2025)
Table 64. Global Therapeutic Monoclonal Antibodies Drug Price (US$/Ton) by Application (2026-2031)
Table 65. AbbVie Therapeutic Monoclonal Antibodies Drug Company Information
Table 66. AbbVie Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 67. AbbVie Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 68. AbbVie Main Business and Markets Served
Table 69. AbbVie Recent Developments/Updates
Table 70. Johnson & Johnson Therapeutic Monoclonal Antibodies Drug Company Information
Table 71. Johnson & Johnson Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 72. Johnson & Johnson Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Johnson & Johnson Main Business and Markets Served
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Novartis Therapeutic Monoclonal Antibodies Drug Company Information
Table 76. Novartis Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 77. Novartis Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Novartis Main Business and Markets Served
Table 79. Novartis Recent Developments/Updates
Table 80. Gilead Sciences Therapeutic Monoclonal Antibodies Drug Company Information
Table 81. Gilead Sciences Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 82. Gilead Sciences Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Gilead Sciences Main Business and Markets Served
Table 84. Gilead Sciences Recent Developments/Updates
Table 85. Roche Therapeutic Monoclonal Antibodies Drug Company Information
Table 86. Roche Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 87. Roche Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Roche Main Business and Markets Served
Table 89. Roche Recent Developments/Updates
Table 90. Bristol-Myers Squibb Therapeutic Monoclonal Antibodies Drug Company Information
Table 91. Bristol-Myers Squibb Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 92. Bristol-Myers Squibb Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Bristol-Myers Squibb Main Business and Markets Served
Table 94. Bristol-Myers Squibb Recent Developments/Updates
Table 95. Amgen Therapeutic Monoclonal Antibodies Drug Company Information
Table 96. Amgen Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 97. Amgen Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Amgen Main Business and Markets Served
Table 99. Amgen Recent Developments/Updates
Table 100. AstraZeneca Therapeutic Monoclonal Antibodies Drug Company Information
Table 101. AstraZeneca Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 102. AstraZeneca Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. AstraZeneca Main Business and Markets Served
Table 104. AstraZeneca Recent Developments/Updates
Table 105. Merck & Co Therapeutic Monoclonal Antibodies Drug Company Information
Table 106. Merck & Co Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 107. Merck & Co Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Merck & Co Main Business and Markets Served
Table 109. Merck & Co Recent Developments/Updates
Table 110. Takeda Therapeutic Monoclonal Antibodies Drug Company Information
Table 111. Takeda Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 112. Takeda Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Takeda Main Business and Markets Served
Table 114. Takeda Recent Developments/Updates
Table 115. Merck KGaA Therapeutic Monoclonal Antibodies Drug Company Information
Table 116. Merck KGaA Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 117. Merck KGaA Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. Merck KGaA Main Business and Markets Served
Table 119. Merck KGaA Recent Developments/Updates
Table 120. Seagen Therapeutic Monoclonal Antibodies Drug Company Information
Table 121. Seagen Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 122. Seagen Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. Seagen Main Business and Markets Served
Table 124. Seagen Recent Developments/Updates
Table 125. Eli Lilly Therapeutic Monoclonal Antibodies Drug Company Information
Table 126. Eli Lilly Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 127. Eli Lilly Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. Eli Lilly Main Business and Markets Served
Table 129. Eli Lilly Recent Developments/Updates
Table 130. Ono Pharmaceutical Therapeutic Monoclonal Antibodies Drug Company Information
Table 131. Ono Pharmaceutical Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 132. Ono Pharmaceutical Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 133. Ono Pharmaceutical Main Business and Markets Served
Table 134. Ono Pharmaceutical Recent Developments/Updates
Table 135. Pfizer Therapeutic Monoclonal Antibodies Drug Company Information
Table 136. Pfizer Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 137. Pfizer Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 138. Pfizer Main Business and Markets Served
Table 139. Pfizer Recent Developments/Updates
Table 140. Regeneron Therapeutic Monoclonal Antibodies Drug Company Information
Table 141. Regeneron Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 142. Regeneron Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 143. Regeneron Main Business and Markets Served
Table 144. Regeneron Recent Developments/Updates
Table 145. Innovent Therapeutic Monoclonal Antibodies Drug Company Information
Table 146. Innovent Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 147. Innovent Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 148. Innovent Main Business and Markets Served
Table 149. Innovent Recent Developments/Updates
Table 150. Hengrui Medicine Therapeutic Monoclonal Antibodies Drug Company Information
Table 151. Hengrui Medicine Therapeutic Monoclonal Antibodies Drug Specification and Application
Table 152. Hengrui Medicine Therapeutic Monoclonal Antibodies Drug Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 153. Hengrui Medicine Main Business and Markets Served
Table 154. Hengrui Medicine Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Therapeutic Monoclonal Antibodies Drug Distributors List
Table 158. Therapeutic Monoclonal Antibodies Drug Customers List
Table 159. Therapeutic Monoclonal Antibodies Drug Market Trends
Table 160. Therapeutic Monoclonal Antibodies Drug Market Drivers
Table 161. Therapeutic Monoclonal Antibodies Drug Market Challenges
Table 162. Therapeutic Monoclonal Antibodies Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Therapeutic Monoclonal Antibodies Drug
Figure 2. Global Therapeutic Monoclonal Antibodies Drug Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Therapeutic Monoclonal Antibodies Drug Market Share by Type: 2024 VS 2031
Figure 4. Mouse-derived Antibodies Product Picture
Figure 5. Chimeric Antibodies Product Picture
Figure 6. Humanized Antibodies Product Picture
Figure 7. Global Therapeutic Monoclonal Antibodies Drug Market Value by Application, (US$ Million) & (2020-2031)
Figure 8. Global Therapeutic Monoclonal Antibodies Drug Market Share by Application: 2024 VS 2031
Figure 9. Immune Diseases
Figure 10. Cancer
Figure 11. Other
Figure 12. Global Therapeutic Monoclonal Antibodies Drug Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Therapeutic Monoclonal Antibodies Drug Production Value (US$ Million) & (2020-2031)
Figure 14. Global Therapeutic Monoclonal Antibodies Drug Production Capacity (Tons) & (2020-2031)
Figure 15. Global Therapeutic Monoclonal Antibodies Drug Production (Tons) & (2020-2031)
Figure 16. Global Therapeutic Monoclonal Antibodies Drug Average Price (US$/Ton) & (2020-2031)
Figure 17. Therapeutic Monoclonal Antibodies Drug Report Years Considered
Figure 18. Therapeutic Monoclonal Antibodies Drug Production Share by Manufacturers in 2024
Figure 19. Global Therapeutic Monoclonal Antibodies Drug Production Value Share by Manufacturers (2024)
Figure 20. Therapeutic Monoclonal Antibodies Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. The Global 5 and 10 Largest Players: Market Share by Therapeutic Monoclonal Antibodies Drug Revenue in 2024
Figure 22. Global Therapeutic Monoclonal Antibodies Drug Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 23. Global Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 24. Global Therapeutic Monoclonal Antibodies Drug Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 25. Global Therapeutic Monoclonal Antibodies Drug Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 26. North America Therapeutic Monoclonal Antibodies Drug Production Value (US$ Million) Growth Rate (2020-2031)
Figure 27. Europe Therapeutic Monoclonal Antibodies Drug Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. China Therapeutic Monoclonal Antibodies Drug Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. Japan Therapeutic Monoclonal Antibodies Drug Production Value (US$ Million) Growth Rate (2020-2031)
Figure 30. Global Therapeutic Monoclonal Antibodies Drug Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 31. Global Therapeutic Monoclonal Antibodies Drug Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 32. North America Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 33. North America Therapeutic Monoclonal Antibodies Drug Consumption Market Share by Country (2020-2031)
Figure 34. U.S. Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 35. Canada Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 36. Europe Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 37. Europe Therapeutic Monoclonal Antibodies Drug Consumption Market Share by Country (2020-2031)
Figure 38. Germany Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 39. France Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 40. U.K. Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 41. Italy Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 42. Russia Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 43. Asia Pacific Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 44. Asia Pacific Therapeutic Monoclonal Antibodies Drug Consumption Market Share by Region (2020-2031)
Figure 45. China Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 46. Japan Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 47. South Korea Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 48. China Taiwan Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 49. Southeast Asia Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 50. India Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 51. Latin America, Middle East & Africa Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 52. Latin America, Middle East & Africa Therapeutic Monoclonal Antibodies Drug Consumption Market Share by Country (2020-2031)
Figure 53. Mexico Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 54. Brazil Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 55. Turkey Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 56. GCC Countries Therapeutic Monoclonal Antibodies Drug Consumption and Growth Rate (2020-2031) & (Tons)
Figure 57. Global Production Market Share of Therapeutic Monoclonal Antibodies Drug by Type (2020-2031)
Figure 58. Global Production Value Market Share of Therapeutic Monoclonal Antibodies Drug by Type (2020-2031)
Figure 59. Global Therapeutic Monoclonal Antibodies Drug Price (US$/Ton) by Type (2020-2031)
Figure 60. Global Production Market Share of Therapeutic Monoclonal Antibodies Drug by Application (2020-2031)
Figure 61. Global Production Value Market Share of Therapeutic Monoclonal Antibodies Drug by Application (2020-2031)
Figure 62. Global Therapeutic Monoclonal Antibodies Drug Price (US$/Ton) by Application (2020-2031)
Figure 63. Therapeutic Monoclonal Antibodies Drug Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
